Rochelle,

I'd like to take a look at the complexity document you have developed.

Thanks, John
 
JOHN HAJNER, CRA
Senior Research Administrator
Office of Sponsored Projects Administration
University of Kentucky
216 Kinkead Hall
Lexington, KY  40506-0057
859-257-4526  fax: 859-323-1060
xxxxxx@email.uky.edu

Seul Dieu peut me juger

OSPA ALERT - Beginning with applications due on or after April 2, 2012, no proposal shall be submitted to any external funding agency unless a fully executed e-IAF has been received by OSPA at least three (3) business days prior to the sponsor's published deadline.  For more information, please see http://www.research.uky.edu/ospa/info/docs/eIAFPolicy_26Jan12.pdf.

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Athey, Rochelle R [VPRED]
Sent: Friday, August 10, 2012 12:37 PM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Sponsored Programs Performance Metrics

We're trying to come up with a measure of complexity.  I have a draft document that splits up our award types into complexity groups from 1 the least complex to  5 most complex.  Let me know if you want a copy.  I want to add the 1-5 complexity rating to our award database and run reports from time to time on complex awards.  It's a very vague measure but it's better than what we have now (nothing).

Rochelle R. Athey, CRA
Director
Office of Sponsored Programs Administration Iowa State University
1138 Pearson Hall
Ames Iowa 50011-2207
Phone:  515-294-7723
Fax:  515-294-8000

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Lawrence Waxler
Sent: Friday, August 10, 2012 10:13 AM
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Sponsored Programs Performance Metrics

Greetings

Like all of you, our lives have become much more complex over the past few years, a trend that I do not see easing up.

Looking back even five years, we didn’t have ARRA reporting, FFATA reporting, increased FCOI requirements, RCR was a smaller issue, and g.g was just cranking up, etc, etc., etc.

I even remember when summer was catch-up time!

However, when measuring what we do, we still rely heavily on how many proposals we process and how many awards we receive as the primary means of determining effectiveness and efficiency despite the fact that these measures do not capture life as we know it today.

So…….does anyone out in grantland have any insight or perspective on how to convey that by way of performance metrics?

Larry

~~~~~~~~~~~~~~~~~~~~~~~
Larry Waxler, Director
Office of Sponsored Programs
University of Southern Maine
15 Baxter Boulevard
P.O. Box 9300
Portland, ME  04104-9300
Telephone: 207-780-4413
Telefax: 207-780-4927

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including  subscription information and a web-searchable archive, are available  via our web site at http://www.healthresearch.org (click on the  "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help ======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including  subscription information and a web-searchable archive, are available  via our web site at http://www.healthresearch.org (click on the  "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help ======================================================================

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.healthresearch.org (click on the
 "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help
======================================================================